ABSTRACT
Observational studies have suggested that beverage intake could have potential connections with irritable bowel syndrome (IBS). However, the association patterns and the underlying mechanisms remain unknown. The study identified potential causal relationships between alcohol intake and IBS, showing positive associations for alcohol intake frequency (odds ratio = 1.18, 95% confidence interval = 1.09–1.26; p < 0.001). Psychiatric disorders were found to play mediative roles with mediation effects of 25.22%, 45.77%, and 12.10% for depression (broad), major depression disease, and attention deficit hyperactivity disorder, respectively. These findings suggest that reducing alcohol intake may help prevent IBS, especially in individuals with psychiatric conditions.
Keywords: alcohol intake, gut microbiota, irritable bowel syndrome, mendelian randomization, psychiatric disorders
Genetic evidence links alcohol to increased IBS risk, mediated by psychiatric factors (25%–45%), informing new management strategies.

Abbreviations
- ADHD
attention deficit hyperactivity disorder
- ASD
autism spectrum disorder
- DHQ
digestive health questionnaire
- FDR
false discovery rate
- GSCAN
GWAS & Sequencing Consortium of Alcohol and Nicotine use
- GWAS
genome‐wide association studies
- IBS
irritable bowel syndrome
- IV
instrumental variable
- IVW
inverse‐variance‐weighted
- LD
linkage disequilibrium
- MDD
major depressive disorder
- MR
Mendelian randomization
- MRC‐IEU
MRC Integrative Epidemiology Unit
- MR‐PRESSO
MR pleiotropy residual sum and outlier
- MVMR
multivariable Mendelian randomization
- OR
odds ratio
- PPD
postpartum depression
- PTSD
post‐traumatic stress disorder
- SNP
single nucleotide polymorphis
1. Introduction
Irritable bowel syndrome (IBS), a chronic functional gastrointestinal disorder characterized by abdominal symptoms and altered bowel habits, impacts 7% to 21% of the global population (Chey et al. 2015; Spiller 2021). The intricate pathological mechanisms underlying IBS remain elusive, with the gut‐brain axis, visceral hypersensitivity, impaired barrier function, and altered gut motility being among the theories proposed to explain its pathogenesis (Ford et al. 2020). Dietary factors play dual roles in IBS: triggers for symptoms but also tools for therapy (El‐Salhy et al. 2019; Pasta et al. 2024). Management of specific dietary factors (e.g., Gluten) has been recognized as an effective possibility for treating IBS (Rej et al. 2022). However, the relationship between beverages, especially alcohol, and IBS remains unclear.
Alcohol is well‐known to have effects on the motility, absorption, and permeability of the gastrointestinal tract (Cozma‐Petruţ et al. 2017; Pohl et al. 2021). However, it is still unknown whether alcohol intake has a causal relationship with IBS. An observational study of women aged 18–48 years with IBS and healthy controls has revealed a positive correlation between high alcohol intake and the gastrointestinal symptoms of IBS patients (Reding et al. 2013). Additionally, another study among 123 female IBS patients with a lower Somatic Symptom Score has indicated that high alcohol intake heightens the risk of IBS (Halder et al. 2006). However, there are studies drawing contrasting conclusions. An investigation has found no significant link between high alcohol intake and IBS (Locke III et al. 2000), while other studies have suggested high alcohol intake is a protective factor for IBS (Yuan et al. 2023).
Previous research has demonstrated that excessive alcohol intake can lead to psychiatric disorders, including depression and anxiety (Jakubczyk et al. 2018; Xu et al. 2022). Furthermore, a meta‐analysis exploring the relationship between alcohol use disorder and major depressive disorder (MDD) concluded that alcohol use disorder increases the risk of developing MDD and vice versa (Boden and Fergusson 2011). Notably, psychiatric disorders frequently coexist with IBS (Fond et al. 2014), with a Mendelian randomization study highlighting the causal association between a broad spectrum of psychiatric conditions, such as depression, MDD, anxiety disorders, post‐traumatic stress disorder (PTSD), and schizophrenia, and IBS (Zhang et al. 2024). These findings underscore the intricate interplay between alcohol intake, mental health, and the gastrointestinal system, but the specific mechanism remains to be discussed.
Alcohol intake has also been reported to induce gut microbiota dysbiosis, specifically characterized by a significant decrease in probiotics and an increase in opportunistic pathogens (Leclercq et al. 2019). For example, alcohol use disorder can lead to decreased levels of anti‐inflammatory bacteria, including Faecalibacterium prausnitzii and Bifidobacterium, and an increased abundance of Proteobacteria (Wang et al. 2020). Previous studies have shown that the abundance of probiotics and pathogens is associated with IBS. A bidirectional Mendelian analysis between 196 bacterial traits and IBS found that several changes in gut microbiota can influence the incidence of IBS (Liu et al. 2023). The above evidence indicated that altered gut microbiota might play a part in the association between alcohol intake and IBS.
In this study, we aimed to clarify the associations between alcohol intake and IBS by performing two‐sample Mendelian analyses. Furthermore, we aimed to identify the possible mediating roles of psychiatric disorders and gut microbiota.
2. Materials and Methods
2.1. Study Design
Mendelian randomization (MR) analyses were performed to investigate the causal effects of alcohol intake on IBS. To be a valid instrument for causal inference in MR studies, genetic variations should meet three fundamental assumptions: (1) the genetic instruments are supposed to have direct associations with exposure; (2) the genetic instruments are supposed to be unrelated to the outcome and independent of any unknown or known confounding factors; (3) exposures of interest mediate the effects of instrumental variables (IVs) on the outcomes (Gu et al. 2023). The design of our study is presented in Figure 1A.
FIGURE 1.

(A) The process and design of our study. (B) The process of the mediation analysis. βa, the effect of exposures on mediators; βb, the effect of mediators on outcomes; βc, the effect of exposures on outcomes; βc′, the effect of exposures outcomes after MVMR adjustment; βb′, the effect of mediators on outcomes after MVMR adjustment; ADHD, attention deficit hyperactivity disorder; IBS, irritable bowel syndrome; MDD, major depression disease; MR, Mendelian randomization; MVMR, Multivariable Mendelian randomization. (C) The graphical abstract of our study.
2.2. Data Sources
Datasets used in our study were shown in Table S1.
2.2.1. Irritable Bowel Syndrome
Genetic instruments for IBS were generated from a genome‐wide association study (GWAS) project including 53,400 cases and 433,201 controls of the European population (Eijsbouts et al. 2021). The inclusion criteria were:
(1) Patients' digestive health questionnaire (DHQ) met Rome III diagnostic criteria without other explanation for their symptoms. (2) The patients had been diagnosed by DHQ self‐reports. (3) The patients had been diagnosed with IBS by gastrointestinal doctors.
2.2.2. Beverage Factors and Alcohol Intake
Genetic instruments of beverage factors, including water intake, milk intake, coffee intake, honey intake, orange juice intake, pure fruit/vegetable juice intake, grapefruit juice intake, and yogurt intake, were collected from the MRC Integrative Epidemiology Unit (MRC‐IEU) (Collins 2012). Genetic instruments associated with alcohol intake frequency were collected from the MRC‐IEU (Zhu et al. 2023). Genetic instruments for the amount of alcohol drink were collected from meta‐analyses of genome‐wide association studies conducted by the GWAS & Sequencing Consortium of Alcohol and Nicotine Use (GSCAN) (Liu et al. 2019).
2.2.3. Psychiatric Diseases and Gut Microbiota
Genetic instruments of psychiatric diseases, including MDD, postpartum depression (PPD), attention deficit hyperactivity disorder (ADHD), PTSD, panic, schizophrenia, autism spectrum disorder (ASD), bipolar disorder, and Tourette syndrome, were collected from the Psychiatric Genomics Consortium (Logue et al. 2015). The statistical data on depression (broad) were obtained from a meta‐analysis comprising 246,363 cases and 561,190 controls (Howard et al. 2019). Genetic instruments of human gut microbiota were collected from the MiBioGen Study, which included 14,306 participants (Kurilshikov et al. 2021).
2.3. Selection of Single Nucleotide Polymorphism (SNP)
In order to ensure the statistical power of IVs, some of the thresholds for p value had been modified. The SNPs should meet the criterion of p < 5e‐06 for the exposures of beverage factors (except for alcohol intake frequency, p < 5e‐08). We selected the SNPs for human gut microbiota, psychiatric diseases, and IBS at p < 5e‐06.
Linkage disequilibrium (LD) indicates that genetic variations in the genome tend to be co‐inherited, resulting in a greater likelihood that alleles from two or more loci will co‐occur on a single chromosome than if they occur randomly (Gui et al. 2023). To obtain IVs from independent loci, we set the threshold for LD at r 2 < 0.001 and kb > 10,000. Here, “kb” represented the extent of regional LD, while the evaluation of “r 2” spanned from 0 to 1. An r 2 value of 1 indicates complete LD between the two SNPs, whereas an r 2 value of 0 signifies complete linkage equilibrium, where the assignment of the two SNPs is entirely random (Rizig et al. 2023).
We extracted the information on effects, other allele, and effect size (β value, standard error, p value) for each SNP. F‐statistics were conducted to evaluate the strength of the IVs. The IV is regarded as weak when the F value is less than 10 (Salehi Nowbandegani et al. 2023). The computational formulas are:
“MAF” is the minor allele frequency of SNPs used as IVs, “k” is the number of IVs employed, and “n” is the sample size. β represents the allele effect size, and SD represents the standard deviation.
2.4. Statistical Analysis
All analyses and graph plotting were performed in R (version 4.3.3). In this study, p < 0.05 was considered statistically significant.
2.4.1. Mendelian Randomization
Three distinct methods were employed for statistical analyses: inverse variance weighting (IVW), MR‐Egger regression, and weighted mode. Among these, IVW served as our primary analytical tool, entailing the consolidation of Wald estimates derived from individual genetic instruments, leveraging summary genotype data to arrive at an overarching estimation. These methods were also prevalent in most MR analysis studies (Burgess et al. 2013), underscoring their robustness. In the context of multiple comparisons, p values were corrected by a Benjamini–Hochberg false discovery rate (FDR) correction in order to mitigate false‐positive risks.
2.4.2. Sensitivity Analysis
The heterogeneity of SNPs was investigated through the IVW and MR‐Egger methods, and the presence of heterogeneity is considered if p < 0.05 (Richardson et al. 2023). The MR‐Egger regression test was utilized to assess pleiotropy, which suggested the IVs could influence the outcome through other factors. The MR pleiotropy residual sum and outlier (MR‐PRESSO) test was used to exclude outliers. Furthermore, the “leave‐one‐out” method was used for a sensitivity analysis to assess outliers. It involves systematically removing the results associated with individual SNPs, evaluating whether they are outliers, and observing the stability of the results after removing each SNP (Cortez Cardoso Penha et al. 2023). Funnel plots were featured to assess the symmetry of SNPs and to show whether the results were credible.
2.4.3. Mediation Analysis
A two‐step, two‐sample MR analysis was performed to investigate the possible mediation factors. Then, multi‐variable MR (MVMR) studies were tested to investigate their direct effects on IBS after mutual adjustment (Zhang et al. 2024). The proportion of mediators was calculated through the Propagation of Error method (Sanderson 2021). The Sobel test was employed to evaluate mediation effects when the GWAS summary data was not fully available and MVMR could not be conducted (Zhang et al. 2024). The process of the mediation analysis is represented in Figure 1B. βa represents the effect of exposures on mediators. βb represents the effect of mediators on outcomes. βc represents the effect of exposures on outcomes, while βb′ and βc′ represent the effect of exposures and mediators on outcomes after MVMR adjustment.
3. Results
3.1. Causal Associations Between Risk of IBS and Beverage Factors
The F‐statistics for the 10 beverage factors were above 10, underscoring their statistical significance. The MR results of the associations between all 10 beverage factors and IBS using the IVW method are presented in Table 1.
TABLE 1.
Effect estimates of the associations of IBS with beverage factors.
| Exposure | GWAS.ID | nSNP | p | p adj | Significance | OR | 95% CI |
|---|---|---|---|---|---|---|---|
| Drinks per week | — | 91 | 1.14E‐04 | 5.70E‐04 | * | 1.26 | 1.12–1.42 |
| Alcohol intake frequency | ukb‐b‐5779 | 79 | 1.10E‐05 | 1.10E‐04 | * | 1.18 | 1.09–1.26 |
| Water intake | ukb‐b‐14898 | 140 | 0.03 | 0.10 | n.s. | 1.16 | 1.01–1.34 |
| Milk intake | ebi‐a‐GCST90096916 | 9 | 0.23 | 0.38 | n.s. | 0.21 | 0.02–2.65 |
| Honey intake | ukb‐b‐6066 | 39 | 0.79 | 0.79 | n.s. | 0.98 | 0.82–1.17 |
| Coffee intake | ukb‐b‐5237 | 39 | 0.31 | 0.39 | n.s. | 0.87 | 0.67–1.13 |
| Orange juice intake | ukb‐b‐2763 | 12 | 0.44 | 0.49 | n.s. | 0.92 | 0.74–1.14 |
| Pure fruit/vegetable juice intake | ukb‐b‐337 | 8 | 0.14 | 0.28 | n.s. | 1.34 | 0.91–1.97 |
| Grapefruit juice intake | ukb‐b‐14351 | 19 | 0.28 | 0.39 | n.s. | 0.80 | 0.53–1.21 |
| Yogurt intake | ukb‐b‐7753 | 9 | 0.06 | 0.15 | n.s. | 0.80 | 0.63–1.01 |
Note: p adj, p value after FDR correction. Drinks per week: the amount of alcohol intake per week. Alcohol intake frequency: the frequency of alcohol intake per week.
Abbreviations: 95% CI, 95% confidence interval; *, Significant; NSNP, the number of single nucleotide polymorphisms; n.s., Not significant; OR, odds ratios.
The results of MR analysis indicated that the frequency of alcohol intake patterns (including alcohol intake frequency, p = 1.10e‐05, p adj = 1.10e‐04, odds ratio (OR) = 1.18; and drinks per week, p = 1.14e‐04, p adj = 5.70e‐04, OR = 1.26) has a possible positive causal relationship with the risk of IBS.
Through additional experiments focusing specifically on alcohol intake and its impact on IBS risk, the results showed that alcohol intake frequency (IVW, p = 1.10e‐05, OR = 1.12; weighted median, p = 1.92e‐02, OR = 1.17) positively correlated with IBS through IVW and weighted median methods (Figure 2A,B, Figures S1 and S2). At the same time, drinks per week (IVW, p = 1.14e‐04, OR = 1.26; MR‐Egger, p = 4.06e‐02, OR = 1.27) showed significant associations with IBS through IVW and MR‐Egger methods (Figure 2A,C, Figures S3 and S4).
FIGURE 2.

(A) The forest map of the association between alcohol and IBS. (B, C) Scatter plots of MR results. CI, confidence interval; OR, odds ratio; SNP, single nucleotide polymorphism.
3.2. Mediation Effect of Gut Microbiota
In 193 bacterial traits, 7 bacterial traits were found to be related to IBS (Table S2). Eight bacterial traits were found to have a reverse relationship with IBS (Table S3). No overlapping bacterial trait was found between the forward and reverse researches. For alcohol intake, “alcohol intake frequency” was used as our exposure. As a result, 21 bacterial traits were found to be significantly related to alcohol intake (Table S4).
However, after applying FDR correction for multiple testing, we did not identify any gut microbiota as potential mediating factors.
3.3. Mediation Effect of Psychiatric Disorders
Our results indicated that alcohol intake could be a risk factor for psychiatric disorders (depression (broad): p = 2.51e‐04, p adj = 6.27e‐04, OR = 1.03; MDD: p = 5.74e‐05, p adj = 1.91e‐04, OR = 1.12; PPD: p = 7.17e‐03, p adj = 1.43e‐02, OR = 1.22; ADHD: p = 4.42e‐09, p adj = 4.42e‐08, OR = 1.37; PTSD: p = 2.12e‐06, p adj = 1.06e‐05, OR = 1.47). Meanwhile, several psychiatric disorders were found to be the risk factors for IBS (depression (broad): p = 6.12e‐18, p adj = 3.06e‐17, OR = 3.44; MDD: p = 2.13e‐30, p adj = 2.13e‐29, OR = 1.32; ADHD: p = 8.74e‐06, p adj = 2.91e‐05, OR = 1.06; schizophrenia: p = 1.09e‐02, p adj = 2.17e‐02, OR = 1.02; bipolar disorder: p = 6.46e‐04, p adj = 1.62e‐03, OR = 1.04). The IVW method was used as the primary analytical tool, and we found that depression (broad), MDD, and ADHD might be potential mediators (Figure 3A,B).
FIGURE 3.

(A) Two‐sample MR analysis between alcohol intake frequency and psychiatric disorders. (B) Two‐sample MR analysis between psychiatric disorders and IBS. (C) Results of the MVMR test. ADHD, attention deficit hyperactivity disorder; ASD, autism spectrum disorder; CI, confidence interval; MVMR, multivariable Mendelian randomization; OR, odds ratio; p adj, p value after FDR correction; PPD, postpartum depression; PTSD, post‐traumatic stress disorder; SNP, single nucleotide polymorphism.
The MVMR method was used to estimate the effects of psychiatric disorders on IBS. Depression (broad) (p = 2.84e‐02, OR = 3.92) and MDD (p = 3.50e‐02, OR = 1.51) were still found to have direct positive effects on IBS (Figure 3C).
Then the MVMR method was utilized to adjust the influence of psychiatric disorders on the effect of alcohol intake. We found a significant attenuation in the effect of genetically predicted alcohol on IBS after the adjustment of depression (broad) and MDD, resulting in βc′ = 0.082 for depression (broad) adjustment and βc′ = −0.009 for MDD adjustment. However, we did not find significant results for ADHD, PTSD, and PPD via the MVMR method. As is shown in Table 2.
TABLE 2.
The results of MR mediation analysis. βa represents the effect of exposures on mediators. βb represents the effect of mediators on outcomes. βc represents the effect of exposures on outcomes. While βb′ and βc′ represent the effect of exposures and mediators on outcomes after MVMR adjustment, respectively.
| Exposure | Outcome | Mediator | βc | βa | βb | βc′ | βb′ | Sobel test | Mediated proportion (%) |
|---|---|---|---|---|---|---|---|---|---|
| Effect size (95% CI) | Effect size (95% CI) | Effect size (95% CI) | Effect size (95% CI) | Effect size (95% CI) | p | ||||
| Alcohol intake frequency | IBS | Depression (broad) | 0.162 (0.090–0.234) | 0.033 (0.015–0.050) | 0.42 (0.321–0.519) | 0.082 (0.019–0.144) | 1.238 (0.911–1.565) | 0.018 | 25.22% a |
| MDD | 0.162 (0.090–0.234) | 0.111 (0.057–0.165) | 0.293 (0.243–0.343) | −0.009 (−0.105–0.087) | 0.668 (0.403–0.933) | < 0.01 | 45.77% a | ||
| ADHD | 0.162 (0.090–0.234) | 0.318 (0.212–0.424) | 0.062 (0.034–0.089) | 0.141 (0.033–0.249) | 0.084 (−0.039–0.207) | < 0.01 | 12.10% b | ||
| PTSD | 0.162 (0.090–0.234) | 0.385 (0.226–0.544) | 0.002 (−0.041–0.045) | 0.114 (0.021–0.207) | −0.017 (−0.124–0.091) | > 0.05 | NA | ||
| PPD | 0.162 (0.090–0.234) | 0.198 (0.054–0.342) | −0.008 (−0.028–0.014) | 0.113 (0.020–0.206) | −0.01 (−0.132–0.111) | > 0.05 | NA |
Note: The results of the MVMR test: p, the p values after the adjustment are less than 0.05; F, the p values after the adjustment are more than 0.05 or unavailable result.
Abbreviation: NA, not available.
Results using the Propagation of Error method.
Results using the Sobel test.
Afterwards, we found that depression (broad) and MDD mediated 25.22% and 45.77% of the effects of alcohol intake on IBS. Sobel tests were performed instead, which indicated that ADHD has a significant mediation effect at a threshold of p < 0.05, which mediated 12.10% of the effects of alcohol intake on IBS.
4. Discussion
In this study, we found positive causal associations between alcohol intake and IBS. Furthermore, our findings indicated that depression (broad), MDD, and ADHD played mediating roles in the causal associations.
The evidence for the association between alcohol and IBS is contradictory. According to a meta‐analysis that summarized 1963 papers, one‐third of these studies suggested that high alcohol intake promotes the occurrence and development of IBS, while the rest indicated that there were protective effects or no effects (Creed 2019). Our study provided higher‐level statistical evidence for the possible role of alcohol intake as a risk factor for IBS through Mendelian Randomization analysis.
Previous studies have found some evidence indicating that a high‐level consumption of alcohol could damage intestinal function (Reding et al. 2013; Halder et al. 2006). Early studies in animals and patients already suggested that alcohol intake can disrupt the intestinal epithelial barrier, resulting in increased gut permeability (Stärkel et al. 2018). Oxidative stress plays a critical role in alcohol‐induced epithelial barrier disruption (Zhong et al. 2010), where the metabolite acetaldehyde can disrupt the epithelial tight junction integrity (Rao 2008). Furthermore, alcohol can have direct effects on the gastrointestinal tract, affecting the mucosa and altering orocecal transit times (Addolorato et al. 1997).
Our results did not identify any significant gut microbiota as mediating factors in the alcohol‐IBS association. However, these findings do not exclude the potential role of gut microbiota in this process. A study has suggested gut microbiota may represent implausible exposures. Some genetic predictors of gut microbiota are located in highly pleiotropic gene regions, such as the ABO gene region (Burgess et al. 2024). This suggests that the genetic predictors of gut microbiota may not necessarily serve as valid instrumental variables. The potential mediating role of gut microbiota in alcohol‐induced IBS pathogenesis needs further investigation.
Previous epidemiologic studies have found that alcohol can cause disruption of gut microbiota, which is the reduction of the abundance of probiotics and an increase of pernicious bacteria (Wang et al. 2020). Alcohol is widely believed to be able to alter the abundance of Lactobacillus, Bifidobacterium, Klebsiella, and other flora in the intestines, which are closely related to intestinal symptoms (Jew and Hsu 2023). Lactobacillus and Bifidobacterium species encode alcohol dehydrogenase and acetaldehyde dehydrogenase, which mediate alcohol and acetaldehyde metabolism (Jung et al. 2021). Alcohol‐related dysbiosis also affects the gut metabolome, including a decrease of short‐chain fatty acids (SCFAs), amino acids, and bile acids (Pohl et al. 2021), which can lead to impaired intestinal epithelial mucosal barrier and immune function, and can aggravate abdominal symptoms (Martin‐Gallausiaux et al. 2021). This evidence suggests that the role of bacteria in the relationship between alcohol and IBS is still worth exploring.
In our study, psychiatric disorders, including depression (broad), MDD, and ADHD, were found to be explicit mediation factors. In both observational and experimental studies, high alcohol intake can lead to an increase in psychiatric disorders (Xu et al. 2022; Boden and Fergusson 2011). Studies have proved that alcohol use disorder and depression share a common genetic predisposition, and dysfunction of the reward and stress systems may be one of the mechanisms of action (McHugh and Weiss 2019).
IBS is a typical disorder of brain‐gut interactions (Mayer et al. 2023). Alcohol affects IBS through the gut‐brain axis via multisystem interactions, including neuroendocrine and immune pathways. Alcohol can modulate neurotransmitter activity. Prolonged alcohol consumption results in the development of tolerance to many of the GABAergic effects of alcohol, including its anxiolytic, sedative, motor incoordinating, and positive reinforcing effects (Koulentaki and Kouroumalis 2018). Alcohol can damage the intestinal barrier, allowing microbial metabolites to enter the bloodstream and trigger immune responses (Stärkel et al. 2018).
The relationships between psychiatric disorders and IBS are widely recognized, especially depression disorders. Clinical observations and research found brain connection alterations in IBS patients, including the salience network, the default mode network, the sensorimotor network, and the central autonomic network, showing the critical role of the brain in generating and maintaining IBS symptoms (Mayer et al. 2023). At the same time, a study based on the Chinese population indicated that IBS patients and depression disease patients share a common genetic predisposition. SYT8 rs3741231 G allele and SSPO rs12536873 TT genotype are associated with both IBS and depression, which of these variants are important in neurogenesis and neurotransmission (Zhu et al. 2020). Therefore, combined with experimental data, we believe that depression is a clear intermediary factor.
ADHD was found to be a positive mediation factor through the Sobel test, while MVMR analysis showed a negative result. ADHD and alcohol use disorder share common genetic, neurobiological, and neuropsychological associations (Luderer et al. 2021). Having ADHD‐related genes, regardless of ADHD status, elevates the risk of alcohol use disorder, with greater risk associated with more genes involved (Wimberley et al. 2020). In addition, children with ADHD are more likely to suffer from functional gastrointestinal diseases (Petropoulos et al. 2024). However, due to the potential for more internalizing problems (such as anxiety and depression) associated with ADHD, ADHD may be an upstream factor for depression. Therefore, in MVMR, after adjusting for depression, the results became insignificant, suggesting that it may not function as a mediating factor in the relationship between alcohol and IBS. Notably, our research suggests that ADHD may be an independent risk factor involved in the pathogenesis of IBS, which warrants further exploration.
There were several limitations. Firstly, the data used in our study were exclusively sourced from European populations, limiting the generalizability of our experimental findings to other populations. Although the GWAS data have achieved remarkable sample sizes, they might still encounter statistical underpowering for certain specific exposure‐outcome associations, particularly those with weaker effects and limited sample sizes. However, by employing various robustness tests, our results had been verified to have strong statistical power.
5. Conclusion
Our study suggested that alcohol intake had causal relationships with IBS from a genetic perspective. Depression (broad), MDD, and ADHD disorders might be mediating factors through the brain‐gut axis. The mediating role of gut microbiota requires alternative research approaches for further elucidation. Further explorations should also be conducted to investigate the underlying mechanisms of how alcohol contributes to the development of IBS. Our findings suggest that reducing alcohol consumption may help reduce the risk of developing IBS, particularly in individuals with psychiatric disorders.
Author Contributions
Ruiqing Yuan: investigation (equal), methodology (equal), software (equal), writing – original draft (lead). Yajing Zhou: conceptualization (lead), data curation (equal), resources (equal), validation (equal). Yujie Ren: formal analysis (equal), methodology (lead), software (equal), visualization (equal). Xiaohua Hou: funding acquisition (equal), methodology (equal), resources (equal), supervision (equal), writing – review and editing (equal). Siran Zhu: conceptualization (equal), funding acquisition (equal), project administration (equal), resources (equal), supervision (equal), writing – review and editing (lead).
Ethics Statement
All participants had given written informed consent in the original GWAS projects.
Conflicts of Interest
The authors declare no conflicts of interest.
Supporting information
Figure S1: Leave‐one‐out plot for alcohol intake frequency on IBS.
Figure S2: Funnel plot for alcohol intake frequency on IBS.
Figure S3: Leave‐one‐out plot for drinks per week on IBS.
Figure S4: Funnel plot for drinks per week on IBS.
Table S1: Datasets used in our analyses.
Table S2: Mendelian randomization results between IBS and gut microbiota features.
Table S3: Mendelian randomization results between gut microbiota features and IBS.
Table S4: Mendelian randomization results between alcohol intake frequency and gut microbiota features.
Table S5: Mendelian randomization results between psychiatric disorders and IBS.
Table S6: Mendelian randomization results between alcohol intake frequency and psychiatric disorders.
Table S7: Details of IVs utilized for alcohol intake frequency.
Table S8: Details of IVs utilized for drinks per week.
Acknowledgments
I would like to express my sincere gratitude to my supervisor, Dr. Siran Zhu, for his guidance and support throughout this research. This work was supported by the National Natural Science Foundation of China. Finally, I would like to thank my family and friends for their constant encouragement.
Yuan, R. , Zhou Y., Ren Y., Hou X., and Zhu S.. 2025. “Mendelian Randomization Analysis Reveals Causal Associations Between Beverages and Irritable Bowel Syndrome: Alcohol, but Not Others.” Food Science & Nutrition 13, no. 8: e70761. 10.1002/fsn3.70761.
Funding: This work was supported by National Natural Science Foundation of China, No. 92268108.
Ruiqing Yuan, Yajing Zhou, and Yujie Ren are contributed equally to this work.
Guarantor of the article: Siran Zhu.
Data Availability Statement
The genetic data for this study are available from MRC‐IEU, GSCAN, Psychiatric Genomics Consortium, and MiBioGen. Detailed data of this study are shown in the Supporting Information and are available from the corresponding author upon reasonable request.
References
- Addolorato, G. , Montalto M., Capristo E., et al. 1997. “Influence of Alcohol on Gastrointestinal Motility: Lactulose Breath Hydrogen Testing in Orocecal Transit Time in Chronic Alcoholics, Social Drinkers and Teetotaler Subjects.” Hepato‐Gastroenterology 44: 1076–1081. [PubMed] [Google Scholar]
- Boden, J. M. , and Fergusson D. M.. 2011. “Alcohol and Depression.” Addiction 106, no. 5: 906–914. 10.1111/j.1360-0443.2010.03351.x. [DOI] [PubMed] [Google Scholar]
- Burgess, S. , Butterworth A., and Thompson S. G.. 2013. “Mendelian Randomization Analysis With Multiple Genetic Variants Using Summarized Data.” Genetic Epidemiology 37, no. 7: 658–665. 10.1002/gepi.21758. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Burgess, S. , Woolf B., Mason A. M., Ala‐Korpela M., and Gill D.. 2024. “Addressing the Credibility Crisis in Mendelian Randomization.” BMC Medicine 22, no. 1: 374. 10.1186/s12916-024-03607-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Chey, W. D. , Kurlander J., and Eswaran S.. 2015. “Irritable Bowel Syndrome: A Clinical Review.” Journal of the American Medical Association 313, no. 9: 949–958. 10.1001/jama.2015.0954. [DOI] [PubMed] [Google Scholar]
- Collins, R. 2012. “What Makes UK Biobank Special?” Lancet 379, no. 9822: 1173–1174. 10.1016/S0140-6736(12)60404-8. [DOI] [PubMed] [Google Scholar]
- Cortez Cardoso Penha, R. , Smith‐Byrne K., Atkins J. R., et al. 2023. “Common Genetic Variations in Telomere Length Genes and Lung Cancer: A Mendelian Randomisation Study and Its Novel Application in Lung Tumour Transcriptome.” eLife 12: e83118. 10.7554/eLife.83118. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Cozma‐Petruţ, A. , Loghin F., Miere D., and Dumitraşcu D. L.. 2017. “Diet in Irritable Bowel Syndrome: What to Recommend, Not What to Forbid to Patients!” World Journal of Gastroenterology 23, no. 21: 3771–3783. 10.3748/wjg.v23.i21.3771. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Creed, F. 2019. “Review Article: The Incidence and Risk Factors for Irritable Bowel Syndrome in Population‐Based Studies.” Alimentary Pharmacology & Therapeutics 50, no. 5: 507–516. 10.1111/apt.15396. [DOI] [PubMed] [Google Scholar]
- Eijsbouts, C. , Zheng T., Kennedy N. A., et al. 2021. “Genome‐Wide Analysis of 53,400 People With Irritable Bowel Syndrome Highlights Shared Genetic Pathways With Mood and Anxiety Disorders.” Nature Genetics 53, no. 11: 1543–1552. 10.1038/s41588-021-00950-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- El‐Salhy, M. , Hatlebakk J. G., and Hausken T.. 2019. “Diet in Irritable Bowel Syndrome (IBS): Interaction With Gut Microbiota and Gut Hormones.” Nutrients 11, no. 8: 1824. 10.3390/nu11081824. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Fond, G. , Loundou A., Hamdani N., et al. 2014. “Anxiety and Depression Comorbidities in Irritable Bowel Syndrome (IBS): A Systematic Review and Meta‐Analysis.” European Archives of Psychiatry and Clinical Neuroscience 264, no. 8: 651–660. 10.1007/s00406-014-0502-z. [DOI] [PubMed] [Google Scholar]
- Ford, A. C. , Sperber A. D., Corsetti M., and Camilleri M.. 2020. “Irritable Bowel Syndrome.” Lancet 396, no. 10263: 1675–1688. 10.1016/S0140-6736(20)31548-8. [DOI] [PubMed] [Google Scholar]
- Gu, Y. , Jin Q., Hu J., et al. 2023. “Causality of Genetically Determined Metabolites and Metabolic Pathways on Osteoarthritis: A Two‐Sample Mendelian Randomization Study.” Journal of Translational Medicine 21, no. 1: 357. 10.1186/s12967-023-04165-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gui, H. , Tang W. H. W., Francke S., et al. 2023. “Common Variants on FGD5 Increase Hazard of Mortality or Rehospitalization in Patients With Heart Failure From the ASCEND‐HF Trial.” Circulation. Heart Failure 16, no. 9: e010438. 10.1161/CIRCHEARTFAILURE.122.010438. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Halder, S. L. , Locke G. R. 3rd, Schleck C. D., Halder S. L. S., Zinsmeister A. R., and Talley N. J.. 2006. “Influence of Alcohol Consumption on IBS and Dyspepsia.” Journal of Neurogastroenterology and Motility 18, no. 11: 1001–1008. 10.1111/j.1365-2982.2006.00815.x. [DOI] [PubMed] [Google Scholar]
- Howard, D. M. , Adams M. J., Clarke T. K., et al. 2019. “Genome‐Wide Meta‐Analysis of Depression Identifies 102 Independent Variants and Highlights the Importance of the Prefrontal Brain Regions.” Nature Neuroscience 22, no. 3: 343–352. 10.1038/s41593-018-0326-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Jakubczyk, A. , Trucco E. M., Kopera M., et al. 2018. “The Association Between Impulsivity, Emotion Regulation, and Symptoms of Alcohol Use Disorder.” Journal of Substance Abuse Treatment 91: 49–56. 10.1016/j.jsat.2018.05.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Jew, M. H. , and Hsu C. L.. 2023. “Alcohol, the Gut Microbiome, and Liver Disease.” Journal of Gastroenterology and Hepatology 38, no. 8: 1205–1210. 10.1111/jgh.16199. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Jung, S. J. , Hwang J. H., Park E. O., et al. 2021. “Regulation of Alcohol and Acetaldehyde Metabolism by a Mixture of Lactobacillus and Bifidobacterium Species in Human.” Nutrients 13, no. 6: 1875. 10.3390/nu13061875. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Koulentaki, M. , and Kouroumalis E.. 2018. “GABA Receptor Polymorphisms in Alcohol Use Disorder in the GWAS Era.” Psychopharmacology 235, no. 6: 1845–1865. 10.1007/s00213-018-4918-4. [DOI] [PubMed] [Google Scholar]
- Kurilshikov, A. , Medina‐Gomez C., Bacigalupe R., et al. 2021. “Large‐Scale Association Analyses Identify Host Factors Infuencing Human Gut Microbiome Composition.” Nature Genetics 53, no. 2: 156–165. 10.1038/s41588-020-00763-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Leclercq, S. , Stärkel P., Delzenne N. M., and de Timary P.. 2019. “The Gut Microbiota: A New Target in the Management of Alcohol Dependence?” Alcohol 74: 105–111. 10.1016/j.alcohol.2018.03.005. [DOI] [PubMed] [Google Scholar]
- Liu, B. , Ye D., Yang H., et al. 2023. “Assessing the Relationship Between Gut Microbiota and Irritable Bowel Syndrome: A Two‐Sample Mendelian Randomization Analysis.” BMC Gastroenterology 23, no. 1: 150. 10.1186/s12876-023-02791-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Liu, M. , Jiang Y., Wedow R., et al. 2019. “Association Studies of up to 1.2 Million Individuals Yield New Insights Into the geneOtic Etiology of Tobacco and Alcohol Use.” Nature Genetics 51, no. 2: 237–244. 10.1038/s41588-018-0307-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Locke, G. R., III , Zinsmeister A. R., Talley N. J., Fett S. L., and Melton L. J.. 2000. “Risk Factors for Irritable Bowel Syndrome: Role of Analgesics and Food Sensitivities.” American Journal of Gastroenterology 95, no. 1: 157–165. 10.1111/j.1572-0241.2000.01678.x. [DOI] [PubMed] [Google Scholar]
- Logue, M. W. , Amstadter A. B., Baker D. G., et al. 2015. “The Psychiatric Genomics Consortium Posttraumatic Stress Disorder Workgroup: Posttraumatic Stress Disorder Enters the Age of Large‐Scale Genomic Collaboration.” Neuropsychopharmacology 40, no. 10: 2287–2297. 10.1038/npp.2015.118. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Luderer, M. , Ramos Quiroga J. A., Faraone S. V., et al. 2021. “Alcohol Use Disorders and ADHD.” Neuroscience and Biobehavioral Reviews 128: 648–660. 10.1016/j.neubiorev.2021.08.026. [DOI] [PubMed] [Google Scholar]
- Martin‐Gallausiaux, C. , Marinelli L., Blottière H. M., Larraufie P., and Lapaque N.. 2021. “SCFA: Mechanisms and Functional Importance in the Gut.” Proceedings of the Nutrition Society 80, no. 1: 37–49. 10.1017/S0029665120006916. [DOI] [PubMed] [Google Scholar]
- Mayer, E. A. , Ryu H. J., and Bhatt R. R.. 2023. “The Neurobiology of Irritable Bowel Syndrome.” Molecular Psychiatry 28, no. 4: 1451–1465. 10.1038/s41380-023-01972-w. [DOI] [PMC free article] [PubMed] [Google Scholar]
- McHugh, R. K. , and Weiss R. D.. 2019. “Alcohol Use Disorder and Depressive Disorders.” Alcohol Research: Current Reviews 40, no. 1: arcr.v40.1.01. 10.35946/arcr.v40.1.01. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Pasta, A. , Formisano E., Calabrese F., et al. 2024. “Food Intolerances, Food Allergies and IBS: Lights and Shadows.” Nutrients 16, no. 2: 265. 10.3390/nu16020265. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Petropoulos, A. , Anesiadou S., Michou M., et al. 2024. “Functional Gastrointestinal Symptoms in Children With Autism and ADHD: Profiles of Hair and Salivary Cortisol, Serum Leptin Concentrations and Externalizing/Internalizing Problems.” Nutrients 16, no. 10: 1538. 10.3390/nu16101538. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Pohl, K. , Moodley P., and Dhanda A. D.. 2021. “Alcohol's Impact on the Gut and Liver.” Nutrients 13, no. 9: 3170. 10.3390/nu13093170. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Rao, R. K. 2008. “Acetaldehyde‐Induced Barrier Disruption and Paracellular Permeability in Caco‐2 Cell Monolayer.” Methods in Molecular Biology 447: 171–183. 10.1007/978-1-59745-242-7_13. [DOI] [PubMed] [Google Scholar]
- Reding, K. W. , Cain K. C., Jarrett M. E., Eugenio M. D., and Heitkemper M. M.. 2013. “Relationship Between Patterns of Alcohol Consumption and Gastrointestinal Symptoms Among Patients With Irritable Bowel Syndrome.” American Journal of Gastroenterology 108, no. 2: 270–276. 10.1038/ajg.2012.414. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Rej, A. , Sanders D. S., Shaw C. C., et al. 2022. “Efficacy and Acceptability of Dietary Therapies in Non‐Constipated Irritable Bowel Syndrome: A Randomized Trial of Traditional Dietary Advice, the Low FODMAP Diet, and the Gluten‐Free Diet.” Clinical Gastroenterology and Hepatology 20, no. 12: 2876–2887. 10.1016/j.cgh.2022.02.045. [DOI] [PubMed] [Google Scholar]
- Richardson, T. G. , Urquijo H., Holmes M. V., and Davey Smith G.. 2023. “Leveraging Family History Data to Disentangle Time‐Varying Effects on Disease Risk Using Lifecourse Mendelian Randomization.” European Journal of Epidemiology 38, no. 7: 765–769. 10.1007/s10654-023-01001-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Rizig, M. , Bandres‐Ciga S., Makarious M. B., et al. 2023. “Identification of Genetic Risk Loci and Causal Insights Associated With Parkinson's Disease in African and African Admixed Populations: A Genome‐Wide Association Study.” Lancet Neurology 22, no. 11: 1015–1025. 10.1016/S1474-4422(23)00283-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Salehi Nowbandegani, P. , Wohns A. W., Ballard J. L., et al. 2023. “Extremely Sparse Models of Linkage Disequilibrium in Ancestrally Diverse Association Studies.” Nature Genetics 55, no. 9: 1494–1502. 10.1038/s41588-023-01487-8. [DOI] [PubMed] [Google Scholar]
- Sanderson, E. 2021. “Multivariable Mendelian Randomization and Mediation.” Cold Spring Harbor Perspectives in Medicine 11, no. 2: a038984. 10.1101/cshperspect.a038984. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Spiller, R. 2021. “Impact of Diet on Symptoms of the Irritable Bowel Syndrome.” Nutrients 13, no. 2: 575. 10.3390/nu13020575. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Stärkel, P. , Leclercq S., de Timary P., and Schnabl B.. 2018. “Intestinal Dysbiosis and Permeability: The Yin and Yang in Alcohol Dependence and Alcoholic Liver Disease.” Clinical Science 132, no. 2: 199–212. 10.1042/CS20171055. [DOI] [PubMed] [Google Scholar]
- Wang, S. C. , Chen Y. C., Chen S. J., Lee C. H., and Cheng C. M.. 2020. “Alcohol Addiction, Gut Microbiota, and Alcoholism Treatment: A Review.” International Journal of Molecular Sciences 21, no. 17: 6413. 10.3390/ijms21176413. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wimberley, T. , Agerbo E., Horsdal H. T., et al. 2020. “Genetic Liability to ADHD and Substance Use Disorders in Individuals With ADHD.” Addiction 115, no. 7: 1368–1377. 10.1111/add.14910. [DOI] [PubMed] [Google Scholar]
- Xu, C. , Xiong Q., Tian X., et al. 2022. “Alcohol Exposure Induces Depressive and Anxiety‐Like Behaviors via Activating Ferroptosis in Mice.” International Journal of Molecular Sciences 23, no. 22: 13828. 10.3390/ijms232213828. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Yuan, S. , Chen J., Ruan X., et al. 2023. “Smoking, Alcohol Consumption, and 24 Gastrointestinal Diseases: Mendelian Randomization Analysis.” eLife 12: e84051. 10.7554/eLife.84051. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Zhang, T. , Chen Y., Li X., Zhang J., and Duan L.. 2024. “Genetic Associations and Potential Mediators Between Psychiatric Disorders and Irritable Bowel Syndrome: A Mendelian Randomization Study With Mediation Analysis.” Frontiers in Psychiatry 15: 1279266. 10.3389/fpsyt.2024.1279266. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Zhong, W. , Zhao Y., McClain C. J., et al. 2010. “Inactivation of Hepatocyte Nuclear Factor‐4{Alpha} Mediates Alcohol‐Induced Downregulation of Intestinal Tight Junction Proteins.” American Journal of Physiology. Gastrointestinal and Liver Physiology 299, no. 3: G643–G651. 10.1152/ajpgi.00515.2009. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Zhu, K. , Shi J., Yang R., Zhou C., and Liu Z.. 2023. “Evidence Based on Mendelian Randomization: Causal Relationship Between Mitochondrial Biological Function and Lung Cancer and Its Subtypes.” Neoplasia 46: 100950. 10.1016/j.neo.2023.100950. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Zhu, S. , He M., Liu Z., Qin Z., Wang Z., and Duan L.. 2020. “Shared Genetic Susceptibilities for Irritable Bowel Syndrome and Depressive Disorder in Chinese Patients Uncovered by Pooled Whole‐Exome Sequencing.” Journal of Advances Research 23: 113–121. 10.1016/j.jare.2020.01.016. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Figure S1: Leave‐one‐out plot for alcohol intake frequency on IBS.
Figure S2: Funnel plot for alcohol intake frequency on IBS.
Figure S3: Leave‐one‐out plot for drinks per week on IBS.
Figure S4: Funnel plot for drinks per week on IBS.
Table S1: Datasets used in our analyses.
Table S2: Mendelian randomization results between IBS and gut microbiota features.
Table S3: Mendelian randomization results between gut microbiota features and IBS.
Table S4: Mendelian randomization results between alcohol intake frequency and gut microbiota features.
Table S5: Mendelian randomization results between psychiatric disorders and IBS.
Table S6: Mendelian randomization results between alcohol intake frequency and psychiatric disorders.
Table S7: Details of IVs utilized for alcohol intake frequency.
Table S8: Details of IVs utilized for drinks per week.
Data Availability Statement
The genetic data for this study are available from MRC‐IEU, GSCAN, Psychiatric Genomics Consortium, and MiBioGen. Detailed data of this study are shown in the Supporting Information and are available from the corresponding author upon reasonable request.
